HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[GHB withdrawal delirium].

Abstract
A 35-year-old man had been using high doses of gamma-hydroxybutyrate (GHB) for many years. He had been trying to cut down on use of this drug for 2 months. He was admitted to the hospital suffering from a withdrawal delirium accompanied by hallucinations and agitation. Use of GHB is increasing in the Netherlands. Along with serious intoxication and dependency, the possibility of withdrawal symptoms should also be taken into consideration. Administration of high doses of benzodiazepines is an effective treatment for these withdrawal symptoms.
AuthorsPetra J E Stijnenbosch, Cassandra Zuketto, Pieter J Beijaert, Anneliek Maat
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 154 Pg. A1086 ( 2010) ISSN: 1876-8784 [Electronic] Netherlands
Vernacular TitleOnthoudingsdelier na het gebruik van GHB.
PMID20132572 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Benzodiazepines
  • Sodium Oxybate
Topics
  • Adult
  • Benzodiazepines (therapeutic use)
  • Delirium (drug therapy, etiology)
  • Hallucinations (drug therapy, etiology)
  • Humans
  • Male
  • Psychoses, Substance-Induced (diagnosis, drug therapy)
  • Sodium Oxybate (administration & dosage, adverse effects)
  • Substance Withdrawal Syndrome (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: